Zimmer Biomet (ZBH) PT Lowered to $137 at BMO Capital; 'Making Very Early Progress, Resetting the Bar'
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $87.47 +3.92%
Rating Summary:
18 Buy, 25 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
18 Buy, 25 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
BMO Capital lowered its price target on Zimmer Biomet (NYSE: ZBH) to $137.00 (from $144.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Bajaj Housing Finance (BAJAJHFL:IN) to Neutral
- Lintec Corp (7966:JP) PT Raised to JPY7,850 at Nomura/Instinet
- Asymchem Laboratories Tianjin Co Ltd (002821:CH) PT Raised to RMB172 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
